TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · major macro event coming up
CCCC

C4 Therapeutics Inc

Healthcare · Biotechnology

3.00$ -1.7% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement CCCC
Line item 2018 2019 2020 2021 2022 2023 2024 2025
– +10.4% +55.3% +37.9% -32.1% -33.3% +71.4% +1.0%
– +66.7% +64.6% -96.3% +160.5% +2.2% +2.0% +1.0%
– – -311.6% – -32.1% -58.1% +173.3% -21.4%
– +68.1% +63.2% +20.7% +24.5% -0.1% -6.0% -5.8%
– +22.5% +73.3% +118.7% +28.7% -1.7% +0.1% -14.1%
– +59.0% -73.2% +741.4% +25.6% -5.3% +2.1% -14.7%
– – – – – – – –
– – -43.0% +74.5% +3.3% -38.0% -100.0% –
– – – – – – – –
– +18.6% -22.1% +242.7% -178.1% – -89.8% -7.6%
– – – – – – – –
– – – – – – – –

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?